The Right RIA For You. All content copyrighted © 2019 – onwards by Ambastha Financial LLC.
By Kuldip K. Ambastha On Thursday, September 1, 2022, the stock of Okta, Inc. (OKTA), a technology company providing cloud-based identity management support for businesses, fell in price by -33.7% per share for the trading day. While 2Q2022 results surpassed Wall Street expectations, areas of concern on a going forward basis drove this sharp decline …
By Kuldip K. Ambastha The stock price of Burlington Stores, Inc. (BURL), an American off-price (discount) department store retailer once known as Burlington Coat Factory, fell by -10.2% per share on the trading day of Thursday, August 25, 2022. 2Q2022 corporate performance results were quite satisfactory, in general. However, 3Q2022 and 2022 corporate performance guidance …
Continue reading “What Caught Our Attention in the Investment World? – Week of August 22-26, 2022”
By Kuldip K. Ambastha On Thursday, June 2, 2022, the stock price of Chewy, Inc. (CHWY) rose by +24.2% per share. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of March 29-April 1, 2021; By Kuldip K. Ambastha.”) Chewy, Inc. (CHWY), an online retailer of pet food and …
Continue reading “What Caught Our Attention in the Investment World? – Week of May 31-June 3, 2022”
By Kuldip K. Ambastha The stock price of Unity Software Inc. (U), a videogame software development company, fell by -37.0% per share on Wednesday, May 11, 2022. In Unity Software’s latest quarterly conference call, company leaders disclosed impressive 1Q2022 results, but also noted disappointing 2Q2022 and 2022 full-year guidance. Wall Street was displeased with the …
Continue reading “What Caught Our Attention in the Investment World? – Week of May 9-13, 2022”
By Kuldip K. Ambastha Sprinklr, Inc. (CXM), an American Software-as-a-Service (SaaS) technology company offering a customer experience management platform (CEMP), had its stock price increase by +21.2% for the trading day of Thursday, April 7, 2022. Sprinklr impressed Wall Street with its most recent quarterly and yearly results on several fronts – earnings, sales, revenues, …
Continue reading “What Caught Our Attention in the Investment World? – Week of April 4-8, 2022”
By Kuldip K. Ambastha Longeveron Inc. (LGVN), a biotechnology company focused on clinical stage therapies, had its stock price rise by +105.4% per share on Thursday, March 31, 2022. On this trading day, a great piece of news led to a great return. Lomecel-B has shown positive results from its Phase 1 trial testing on …
By Kuldip K. Ambastha The stock of Accenture plc (ACN), a multinational professional services company which is strong in information technology (IT) services and consulting, was up by +6.7% for the trading day of Thursday, December 16, 2021. Accenture delivered impressive quarterly results for the past quarter, with earnings and revenues both surpassing estimates by …
Continue reading “What Caught Our Attention in the Investment World? – Week of December 13-17, 2021”
By Kuldip K. Ambastha On Tuesday, November 9, 2021, shares of Roblox Corporation (RBLX), an online gaming and entertainment platform which brings people together over common interests, shot up by +42.2% for the trading day. (See What Caught Our Attention in the Investment World? – Week of March 8-12, 2021; By Kuldip K. Ambastha for …
Continue reading “What Caught Our Attention in the Investment World? – Week of November 8-12, 2021”
By Kuldip K. Ambastha On Tuesday, November 2, 2021, Avis Budget Group, Inc. (CAR) returned +108.3% and Chegg, Inc. (CHGG) returned -48.8% for the trading day. Avis, a vehicle rental and mobility solutions company, delivered strong 3Q2021 results and has announced a pledge to expand into using electric vehicles in the future. Avis has benefited …
Continue reading “What Caught Our Attention in the Investment World? – Week of November 1-5, 2021”
By Kuldip K. Ambastha On Friday, September 3, 2021, the stock of Forte Biosciences, Inc. (FBRX) stood out for its substantial trading day loss of -82.3%. Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on potential treatments for inflammatory skin diseases. The company released results of a Phase 2 clinical trial of FB-401, related …